2019-11-11 09:36:00 Mon ET
technology antitrust competition bilateral trade free trade fair trade trade agreement trade surplus trade deficit multilateralism neoliberalism world trade organization regulation public utility current account compliance
Apple upstream semiconductor chipmaker TSMC boosts capital expenditures to $15 billion with almost 10% revenue growth by December 2019. Due to high global demand for faster mobile microchips and new 5G high-end smart phones, TSMC expects robust revenue and net profit growth in 2020-2022. This bullish prediction helps assuage both investor fear and anxiety in the early resolution of uncertainty around the Sino-American interim partial trade agreement. TSMC CEO C.C. Wei expects to attain 20%+ 5G smartphone market penetration for 2020. As of 2019Q4, TSMC serves several clients such as Apple, HuaWei, and Qualcomm worldwide.
Meanwhile, TSMC raises its new capital expenditures to $15 billion from an earlier conservative forecast of $10 billion for the fiscal year 2020. In recent years, TSMC surpasses its U.S. archrival Intel to become the biggest high-performance micro-chip producer as TSMC maintains its $250 billion stock market capitalization in comparison to $230 billion stock market capitalization for Intel.
From January 2019 to September 2019, TSMC ships 185 million smart phones. In fact, this achievement is only second to the Chinese tech titan HuaWei. In essence, the robust stock market momentum among HuaWei, Intel, and TSMC etc suggests that a major global tech slowdown seems less likely in the current business cycle.
If any of our AYA Analytica financial health memos (FHM), blog posts, ebooks, newsletters, and notifications etc, or any other form of online content curation, involves potential copyright concerns, please feel free to contact us at service@ayafintech.network so that we can remove relevant content in response to any such request within a reasonable time frame.
2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be
2019-06-13 10:26:00 Thursday ET

The Chinese Xi administration may choose to leverage its state dominance of rare-earth elements to better balance the current Sino-U.S. trade war. In recent
2018-10-07 13:39:00 Sunday ET

The U.S. greenback soars in value as the Federal Reserve continues its interest rate hike. With impressive service-sector data and non-farm payroll wage gro
2023-06-21 12:32:00 Wednesday ET

Michael Sandel analyzes what money cannot buy in stark contrast to the free market ideology of capitalism. Michael Sandel (2013) What money
2020-07-19 09:25:00 Sunday ET

Senior business leaders can learn much from the lean production system with iterative continuous improvements at Toyota. Takehiko Harada (2015)
2019-07-07 18:36:00 Sunday ET

The Chinese central bank has to circumvent offshore imports-driven inflation due to Renminbi currency misalignment. Even though China keeps substantial fore